Treatment
-
How Common Are Treatment Breakthroughs?A new study adds nuance to the ‘golden age’ of cancer drug approvals.
by Jon Kelvey
-
New Guidelines Recommend Exercise for Most Cancer PatientsPeople in treatment for early-stage cancer should try to get exercise, according to new recommendations.
by Sandra Gordon
-
Forward Look
What’s NextNanoscopic biological computer kills cancer cells, spares healthy ones.
by Natalie Slivinksi
-
Forward Look
Drug Combinations for Advanced MelanomaResearchers find that when treating metastatic melanoma, timing is everything.
by Erin O'Donnell
-
From the Editor-in-Chief
RAS as an ‘Undruggable’ Drug TargetNew therapies are being developed to attack a previously untreatable cancer mutation.
by William G. Nelson, MD, PhD
-
Exploring Amino Acids’ Impact on Tumor GrowthResearchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
-
Forward Look
Comparing Antibody-Drug Conjugates for Metastatic Breast CancerResults favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
by Kris Conner
-
Forward Look
Who Benefits From Immunotherapy?Success of immune checkpoint inhibitors in clinical trials does not always carry over to patients in the clinic.
by Delia O'Hara
-
Forward Look
Fasting-Mimicking Diet Increases Anti-Tumor ImmunityResearch suggests short bursts of intense calorie restriction could improve treatment response in patients with a range of cancers.
by Robin Donovan
-
Forward Look
Coordination of CarePilot program emphasizes standards to streamline patient care.
by Carolyn Bernhardt
